Notification regarding Ambea’s holding of own shares

After repurchases completed in accordance with a share repurchase program resolved on by the board of directors of Ambea AB (publ), the company’s holding of own shares on 22 February 2023 amounted to 4 757 388 shares, which corresponds to 5,03 percent of the total numbers of shares and votes in the company. The company’s holding of own shares thus exceeds five percent of the total numbers of shares and votes in the company.

The repurchases of own shares have been made by virtue of an authorisation from the Annual General Meeting 2022 to repurchase shares and in accordance with the board of directors’ resolution to utilise the authorisation by initiating a share repurchase program which the company published information about by press release on 2 November 2022.

At the time of this press release, the total number of shares and votes in the company is 94,617,996.

This is information is information that Ambea AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the mentioned contact person, at 15.00 CET on February 23 2023.

This disclosure contains information that Ambea is obliged to make public pursuant to the Swedish Financial Instruments Trading Act (1991:980). The information was submitted for publication, through the agency of the contact person, on 23-02-2023 15:00 CET.

For more information, contact:

Susanne Vogt, head of IR
E-mail: ir@ambea.se

Ambea press contact
Telephone: +46 (0)10 33 00 501
E-mail: press@ambea.se

Ambea is the market leading care provider in Sweden, Norway and Denmark respectively, with over 950 care units and around 31,000 employees. We offer services in disabled care, individual and family care, and elderly care with a focus on residential care and own management. We aim to be the quality leader in all that we do and our vision is to make the world a better place, one person at a time. The company was founded in 1996 and its head office is located in Solna, Sweden. Ambea is listed on Nasdaq Stockholm.